GC BIOPHARMA CORP. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 115,800 KRW | +1.31% |
|
+1.05% | -7.73% |
| 06-10 | FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A | CI |
| 05-20 | Gc Biopharma and Novel Pharma Announce Sanfilippo Syndrome Treatment Obtains FDA IND Approval | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 119,900.00 | 126,800.00 | 125,500.00 |
| Spread/Res. | -3.42% | -8.68% | -7.73% |
| Spread/Supp. | +4.70% | +7.12% | +22.41% |
| Support | 110,600.00 | 108,100.00 | 94,600.00 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- A006280 Stock
- Charts GC Biopharma Corp.
